Location of Repository

Metabolic and serotonergic modulation of hypothalamic arcuate nucleus neurones in vitro

By Louise Saker


1. The effects of glucose on the electrophysiological properties of rat hypothalamic arcuate nucleus (ARC) neurones were investigated. Neurones were recorded in 10 mM (hyperglycaemic) and 2 mM (euglycaemic) glucose-containing aCSF. The major findings were that input resistance increased in 10 mM glucose, there was an increase in the activity of neurones in 2 mM glucose and there were a greater percentage of neurones expressing lh in 10 mM glucose. Subthreshold active conductances were differentially expressed in ARC neurones including: anomalous inward rectification Q. ), time- and voltage-dependent inward rectification 00, A-like transient outward rectification (IA) and T-type calcium-like conductance. Characterisation of the differential expression of these conductances may represent one way of functionally classifying ARC neurones. \ud 2. Whole-cell patch clamp recording techniques were used in isolated hypothalamic brain slice preparations to investigate the effects of 5-HT on ARC neurones. Bath application of 5-HT induced a membrane depolarisation in a sub-population of ARC neurones (30%), a response that persisted in the presence of TTX indicating a direct effect. 5-HT excited ARC neurones through three potential mechanisms: closure of one or more resting potassium conductances; activation of a non-selective cation channel, or a combination of the two; or activation of a pump in the membrane. This response was mediated through the 5-HT2A. 5-HT2B and/or 5-HT2C receptors revealed using a range of 5-HT receptor agonists and antagonists. 5-HT was shown to excite CART-expressing neurones suggesting an anorexigenic role for 5-HT, via 5-HT2 receptors at the level of the ARC.\ud 3.5-HT induced a membrane hyperpolarisation in a sub-population of ARC neurones (37%). The 5-HT-induced hyperpolarisation persisted in the presence of TTX indicating a direct effect on ARC neurones. 5-HT inhibited ARC neurones most likely through the activation of one or more potassium conductances,including an inwardly rectifying potassium conductance. Potential roles for 5-HTIA, 5-HTIB and 5-HT7 receptors were suggested from studies utilising 5-HT receptor agonists and antagonists. 5-HT inhibited orexigenic NPY/AgRP neurones, identified by their response to ghrelin and by their electrophysiological properties, suggesting an anorexigenic role for 5-HT, acting via 5-HTI and 5-HT7 receptors on NPY/AgRP neurones at the level of the ARC. \ud 4. The effects of feeding-related signals on hypothalamic neuropeptide expression were investigated using real-time-PCR. A new protocol measuring gene expression from hypothalamic explants was developed. Effects of GABA and AMPA on c-fos expression were investigated and subsequent studies showed leptin and glucose modulated the expression of NPY, POMC and AgRP, in fed and fasted animals. Further work is required to validate this novel approach to studying the central control of energy balance

Topics: RC0321, QM
OAI identifier: oai:wrap.warwick.ac.uk:3372

Suggested articles



  1. 1). Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats.
  2. (2002). 5-HTIA receptor immunoreactivity in hypothalamic neurons involved in body weight control.
  3. (1987). 5-HTIB agonists induce anorexia at a postsynaptic site.
  4. (2002). 5-HTIB receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotoninlB agonist CP-94,253. Psychopharmacology (Berl)
  5. (1989). 5-HTIc receptor is a prominent serotonin receptor subtype in the central nervous system.
  6. (1994). 5-Hydoxytryptamine evokes depolarizations and membrane potential oscillations in rat sympathetic preganglionic neurones.
  7. (2005). 5-Hydroxytryptamine induced excitation and inhibition in the subtlialamic nucleus: action at 5-HT(2C), 5-HT(4) and 5-HT(IA) receptors,
  8. (1991). 5-Hydroxytryptamine2 and 5-hydroxytryptamine IA receptors mediate opposing responses on membrane excitability in rat association cortex.
  9. (1986). 8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance.
  10. (1998). A frameshift mutation in MC4R associated with dominantly inherited human obesity.
  11. (2004). A new ATPsensitive K+ channel-independent mechanism is involved in glucose-excited neurons of mouse arcuate nucleus.
  12. (2008). A O'Rahilly S& Heisler LK.
  13. (2001). A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans.
  14. (1996). A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5 -ht7 receptor in rat brain.
  15. (1996). A receptor subtype involved in neuropeptide-Y-induced food intake.
  16. (1999). A review of central 5-HT receptors and their ftinction.
  17. (2001). A role for ghrelin in the central regulation of feeding.
  18. (1996). A role for melanin-concentrating hormone in the central regulation of feeding behaviour.
  19. (1971). a). Prediction of repetitive firing behaviour from voltage clamp data on an isolated neurone soma.
  20. (1996). Abnormal splicing of the leptin receptor in diabetic mice.
  21. (1998). Absence of fenfluramine-induced anorexia and reduced c-Fos induction in the hypothalamus and central amygdaloid complex of serotonin IB receptor knock-out mice.
  22. (1986). ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists.
  23. (1996). Activation by intracellular ATP of a potassium channel in neurones from rat basomedial hypothalamus.
  24. (1997). Activation of 5-HT213 receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat.
  25. (2002). Activation of central melanocortin pathways by fenfluramine.
  26. (1990). Activity dependent regulation of BDNF and NGF mRNAs in the rat hippocampus is mediated by non-NMDA glutarnate receptors.
  27. (1964). Activity of Single Neurons in the Hypothalamic Feeding Centers: Effect of Glucose.
  28. (2007). Activitydependent release of transforming growth factor-beta in a neuronal network in vitro.
  29. (2002). Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers.
  30. (2008). Acute effects of leptin require P13K signaling in hypothalamic proopiornelanocortin neurons in mice.
  31. (2003). Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse.
  32. (2003). Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression.
  33. (2007). Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake.
  34. (2005). Agouti-related peptide-expressing neurons are mandatory for feeding.
  35. (2003). Agouti-related peptide, neuropeptide Y, and somatostatin-producing neurons are targets for ghrelin actions in the rat hypothalamus.
  36. (1978). alpha-Melanocyte stimulating hormone: immunchistochemical identification and mapping in neurons of rat brain.
  37. (2004). AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.
  38. (2007). AMPK is essential for energy horneostasis regulation and glucose sensing by POMC and AgRP neurons.
  39. (1978). An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat.
  40. (1979). An autoradiographic study of the efferent connections of the lateral hypothalamic area in the rat.
  41. (1979). An autoradiographic study of the efferent connections of the ventromedial nucleus of the hypothalamus.
  42. (1978). Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat.
  43. (1985). Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides 6 Suppl 2,1-11. Chua
  44. (2005). Anatomy and regulation of the central melanocortin system.
  45. (1990). Anatomy of the serotonergic system.
  46. (1997). Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein.
  47. (2003). Antagonism of ghrelin receptor reduces food intake and body weight gain in mice.
  48. appetite and increases food intake in humans.
  49. (2000). ARC POMC rnRNA and PVN alpha-MSH are lower in obese relative to lean zucker rats.
  50. (1995). Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat.
  51. (1991). Arcuate nucleus projections to brainstern regions which modulate nociception.
  52. (2001). ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis.
  53. (1996). Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.
  54. Autoradiographic analysis of ghrelin receptors in the rat hypothalamus.
  55. (1996). Behavioural evidence that dfenfluramine-induced anorexia in the rat is not mediated by the 5-HTIA receptor subtype. Psychopharmacology (Berl)
  56. (2005). Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BlIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.
  57. (2004). Brain circuits regulating energy homeostasis.
  58. (1999). Brain glucose sensing and body energy homeostasis: role in obesity and diabetes.
  59. (2005). Brain regulation of food intake and appetite: molecules and networks.
  60. (1983). Brain-blood barrier? Yes and no.
  61. (1997). BW 723C86, a 5-HT213 receptor agonist, causes hyperphagia and reduced grooming in rats.
  62. (1994). Calcium regulation of gene expression in neuronal cells.
  63. (1995). Calcium signaling in neurons: molecular mechanisms and cellular consequences.
  64. (1998). Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Yl receptor.
  65. (1998). CART peptides in the central control of feeding and interactions with neuropeptide Y.
  66. (2005). CCK and 5-HT act synergistically to suppress food intake through simultaneous activation of CCK-I and 5-HT3 receptors. Peptides 26,2322-2330.
  67. (2000). Cellular localization of serotonin(2A) (5HT(2A)) receptors in the rat brain.
  68. (2002). Central administration of oleic acid inhibits glucose production and food intake.
  69. (2000). Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression.
  70. (1990). Central effects of CRF on metabolism and energy balance.
  71. (2000). Central nervous system control of food intake.
  72. (2006). Changes in extracellular hypothalamic glucose in relation to feeding.
  73. (2003). Changes in hypothalamic expression levels of galanin-like peptide in rat and mouse models support that it is a leptin-target peptide.
  74. (2001). Characterization of CART neurons in the rat and human hypothalamus.
  75. (2007). Characterization of glucosensing neuron subpopulations in the arcuate nucleus: integration in neuropeptide Y and pro-opio melanocortin networks?
  76. (1998). Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area.
  77. (1973). Cholecystokinin decreases food intake in rats.
  78. (2001). Chronic central infusion of ghrelin increases hypothalamic neuropeptide Y and Agouti-related protein mRNA levels and body weight in rats.
  79. (1993). Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity.
  80. (2000). Circumventricular organs: definition and role in the regulation of endocrine and autonomic function.
  81. (1992). Clinical studies with Menfluramine.
  82. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.
  83. (1999). Co-localization of growth hormone secretagogue receptor and NPY rnRNA in the arcuate nucleus of the rat.
  84. (1998). Cocaine- and amphetamine-regulated transcript peptide immunohistochernical localization in the rat brain.
  85. (1998). Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons.
  86. (1996). Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus.
  87. (1991). Comparative anatomical distribution of 5-HTIA receptor mRNA and 5-HTIA binding in rat brain--a combined in situ hybridisation/in vitro receptor autoradiographic study.
  88. (1995). Comparative localization of serotonin
  89. (2001). Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus.
  90. (1997). CP-94,253: a selective serotoninlB (5-HTIB) agonist that promotes satiety. Psychopharmacology (Berl)
  91. (2002). Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats.
  92. (2006). Different levels of Ih determine distinct temporal integration in bursting and regular-spiking neurons in rat subiculum.
  93. (1993). Differential effect of fasting on hypothalamic expression of genes encoding neuropeptide Y, galanin, and glutamic acid decarboxylase.
  94. (2007). Differential effects of fasting and leptin on proopiomelanocortin peptides in the arcuate, nucleus and in the nucleus of the solitary tract.
  95. (1996). Differential effects of the 5-HT lB/2C receptor agonist mCPP and the 5-HTIA agonist flesinoxan on hypothalamic neuropeptide Y in the rat: evidence that NPY may mediate serotonin's effects on food intake.
  96. (2008). Discovery and structure-activity relationship of (IR)-8-chloro2,3,4,5-tetrahydro-l-methyl-IH-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity.
  97. (1999). Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinernia.
  98. (1992). Distribution and cellular localization of mRNA coding for 5-HTIA receptor in the rat brain: correlation with receptor binding.
  99. (1997). Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues.
  100. (1989). Distribution of serotonin 5-HT IC receptor rnRNA in adult rat brain.
  101. (2002). Distribution of serotonin 5-hydroxytriptamine IB (5-HT(IB)) receptors in the normal rat hypothalamus.
  102. (2007). Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant.
  103. (1995). Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors.
  104. (2004). Effect of 5-HTIA receptor activation on hypothalamic glucose.
  105. (1981). Effects of a new type of 5-HT receptor agonist on male rat sexual behavior.
  106. (1988). Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats.
  107. (2005). Effects of fasting, leptin, and insulin on AGRP and POMC peptide release in the hypothalamus.
  108. (2005). Effects of hypothalamic neurodegeneration on energy balance.
  109. (1998). Effects of leptin on corticotropinreleasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice.
  110. Effects of leptin receptor mutation on Agrp gene expression in fed and fasted lean and obese (LA/N-faf) rats.
  111. (2000). Effects of selected serotonin 5-HT(l) and 5-HT(2) receptor agonists on feeding behavior: possible mechanisms of action.
  112. (2008). Effects of selective modulation of the central melanocortin-3 -receptor on food intake and hypothalamic POMC expression.
  113. (1997). Effects of serotonin on caudal raphe neurons: activation of an inwardly rectifying potassium conductance. i Neurophysiol 77,1349-1361.
  114. (1995). Effects of the obese gene product on body weight regulation in ob/ob mice.
  115. (1991). Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding.
  116. (2007). Electrical inhibition of identified anorexigenic POMC neurons by orexin/hypocretin.
  117. (1981). Electrophysiology of mammalian inferior olivary neurones in vitro. Different types of voltage-dependent ionic conductances.
  118. (2002). Elevated plasma ghrelin levels in Prader Willi syndrome.
  119. (1994). Enhanced aggressive behavior in mice lacking 5-HT113 receptor.
  120. (1994). Erecinska A
  121. (1987). Evidence for a possible functional interaction between serotonergic and cholinergic mechanisms in memory retrieval.
  122. (1997). Evidence for expression of the 5-hydroxytryptamine-213 receptor protein in the rat central nervous system.
  123. (2004). Evidence for hypothalamic K+(ATP) channels in the modulation of glucose homeostasis.
  124. (2006). Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding.
  125. (2001). Evidence of an orexigenic role for cocaine- and amphetamineregulated transcript after administration into discrete hypothalamic nuclei.
  126. (1998). Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus.
  127. (2002). Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI. JNeurosci 22,9635-9642. Zhang
  128. (1989). Evidence that d-fenfluramine anorexia is mediated by S-HTI receptors. Psychopharmacology (Berl)
  129. (2001). Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors.
  130. (1988). Evidence that hypophagia induced by mCPP and TFMPP requires 5-HTIC and 5-HTIB receptors; hypophagia induced by RU 24969 only requires 5-HTIB receptors. Psychopharmacology (Berl)
  131. (1988). Evidence that the hyperphagic responseto 8-OH-DPAT is mediatedby 5-HTIA receptors.
  132. (1993). Excitatory and indirect inhibitory actions of 5-hydroxytryptamine on sympathetic preganglionic neurones in the neonate rat spinal cord in vitro.
  133. (2005). Excitatory effects of serotonin on rat striatal cholinergic interneurones.
  134. (2006). Expression of ghrelin receptor mRNA in the rat and the mouse brain.
  135. (2003). Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat.
  136. (2003). Extracellular glucose in rat ventromedial. hypothalamus during acute and recurrent hypoglycernia.
  137. (1983). Fast inward-rectifying current accounts for anomalous rectification in olfactory cortex neurones.
  138. (1997). Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine.
  139. (1989). Feeding increases extracellular serotonin in the lateral hypothalamus of the rat as measured by microdialysis.
  140. (1988). Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus.
  141. (1999). Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action.
  142. (2002). Functional subsets of serotonergic neurones: implications for control of the hypothalamic-pituitary-adrenal axis.
  143. (1999). functions of cholecystokinin receptors.
  144. (2004). GABA release from proopiomelanocortin neurons.
  145. (2001). GABAergic nature of hypothalamic leptin target neurones in the ventromedial arcuate nucleus.
  146. (2008). Gastrointestinal peptides controlling body weight homeostasis.
  147. (2007). Gastrointestinal regulation of food intake.
  148. (2000). Ghrelin induces adiposity in rodents.
  149. (1999). Ghrelin is a growth-hormone-releasing acylated peptide from stomach.
  150. (2001). Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin.
  151. (2005). Ghrelin is an orexigenic and metabolic signaling peptide in the arcuate and paraventricular nuclei.
  152. (2000). Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.
  153. (2001). Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.
  154. (2005). Ghrelin: structure and function.
  155. (2006). Glucokinase is a critical regulator of ventromedial hypothalamic neuronal glucosensing.
  156. (2002). Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons.
  157. (2007). Glucokinase regulates reproductive function, glucocorticoid secretion, food intake, and hypothalamic gene expression.
  158. (2007). Glucose sensing by hypothalamic neurones and pancreatic islet cells: AMPle evidence for common mechanisms? Exp Physiol 92,311-319.
  159. (2001). Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus.
  160. (1990). Glucose-induced excitation of hypothalamic neurones is mediated by ATP-sensitive K+ channels.
  161. (2005). Glucose-sensing neurons of the hypothalamus.
  162. (2002). Glucose-sensing neurons: are they physiologically relevant?
  163. (1999). Glucose-sensitive neurons in the rat arcuate nucleus contain neuropeptide Y. Neurosci Lett 264,113-116. Murphy TH,
  164. (1953). Glucostatic mechanism of regulation of food intake.
  165. (2002). Gut hormone PYY(3-36) physiologically inhibits food intake.
  166. (1997). Heterogeneity in the neuropeptide Y-containing neurons of the rat arcuate nucleus: GABAergic and non-GABAergic subpopulations.
  167. (2000). How tight are your genes? Transcriptional and posttranscriptional regulation of the leptin receptor, NPY, and PONIC genes.
  168. (1976). Hyperphagia and increased growth in rats after intraventricular injection of 5,7-dihydroxytryptamine.
  169. (1976). Hyperphagia. and obesity following serotonin depletion by intraventricular p-chlorophenylalanine.
  170. (2003). Hyperphagic effects of brainstem ghrelin administration.
  171. (1998). Hypocretin/orexinand melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems.
  172. (1999). Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting.
  173. (1998). Hypothalamic CART is a new anorectic peptide regulated by leptin.
  174. (1999). Hypothalamic cocaine- and amphetamine-regulated transcript (CART) neurons: histochernical relationship to thyrotropin-releasing hormone, melanin-concentrating hormone, orexin/hypocretin and neuropeptide Y.
  175. (1997). Hypothalamic expression of ART, a novel gene related to agouti, is upregulated in obese and diabetic mutant mice.
  176. (2002). Hypothalamic insulin signaling is required for inhibition of glucose production.
  177. (2002). Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphetamine-regulated transcript and alpha-melanocyte-stimulating hormone in vitro in male rats.
  178. (2005). Hypothalamic K(ATP) channels control hepatic glucose production.
  179. (1940). Hypothalamic lesions and adiposity in the rat. The Anatomical Record 78,149-172.
  180. (1990). Hypothalamic neuropeptide Y (NPY) in obese Zucker rats: implications in feeding and sexual behaviors.
  181. (2002). Hypothalamic NPY, AGRP, and POMC mRNA responses to leptin and refeeding in mice.
  182. (2002). Hypothalamic paraventricular 5-hydroxytryptamine: receptor-specific inhibition of NPY-stimulated eating and energy metabolism.
  183. (2003). Hypothalamic proopiornelanocortin neurons are glucose responsive and express K(ATP) channels.
  184. (2005). Hypothalamic regulation of sleep and circadian rhythms.
  185. (1995). Identification and expression cloning of a leptin receptor, 013-R.
  186. (2005). Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus.
  187. (2003). Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone.
  188. Identification of targets of leptin action in rat hypothalamus.
  189. (2005). Identifying hypothalamic pathways controlling food intake, body weight, and glucose homeostasis.
  190. (1997). Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system.
  191. (1989). In primary cultures of cerebellar granule cells the activation of N-methyl-D-aspartate-sensitive glutamate receptors induces c-fos mRNA expression.
  192. (1996). Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor pchlorophenylalanine.
  193. (1990). Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation.
  194. (1990). Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats.
  195. (1993). Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse.
  196. (1998). Induction of neuropeptide Y expression in dorsomedial hypothalamus of diet-induced obese mice.
  197. (1992). Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
  198. (2005). Inhibitory effect of 5-hydroxytryptamine on hyperphagia in mice with genetic overexpression of neuropeptide Y. Neurosci Lett.
  199. (2000). Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats.
  200. (2006). Integration of metabolic stimuli in the hypothalamic arcuate nucleus.
  201. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev
  202. (2006). Intracellular signalling pathways activated by leptin.
  203. (1979). Intrahypothalarnic connections: an electron microscopic study in the rat.
  204. (1994). Intrathalamic rhythmicity studied in vitro: nominal T-current modulation causes robust antioscillatory effects.
  205. (1986). Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats.
  206. (1999). Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action.
  207. (1977). Is there a role for serotonin (5-hydroxytryptamine) in feeding?
  208. (1988). Ketanserin antagonises the anorectic effect of DL-fenfluramine in the rat.
  209. (2001). Leptin activates anorexigenic pOMC neurons through a neural network in the arcuate nucleus.
  210. (2004). Leptin and insulin stimulation of signalling pathways in arcuate nucleus neurones: P13K dependent actin reorganization and KATP channel activation.
  211. (1998). Leptin and the regulation of body weight in mammals.
  212. (1997). Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus.
  213. (1997). Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels.
  214. (1998). Leptin receptor immunoreactivity in chemically defined target neurons of the hypothalamus.
  215. (1999). Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus.
  216. (2001). Leptin regulation of Agrp and Npy mRNA in the rat hypothalamus.
  217. (2000). Leptin regulation of prepro-orexin and orexin receptor MRNA levels in the hypothalamus.
  218. (1998). Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene.
  219. (2001). Localization of 5-HT(7) receptors in rat brain by immunocytochernistry, in situ hybridization, and agonist stimulated cFos expression.
  220. (1951). Localization of a "feeding center" in the hypothalamus of the rat.
  221. (1984). Localization of forebrain neurons which project directly to the medulla and spinal cord of the rat by retrograde tracing with wheat germ agglutinin.
  222. (1990). Localization of insulin receptor mRNA in rat brain by in situ hybridization.
  223. (1995). Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochernistry.
  224. (1994). Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain.
  225. (1985). Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl)
  226. (1996). Low-threshold calcium currents in central nervous system neurons.
  227. (2007). Making sense of it: roles of the sensory circumventricular organs in feeding and regulation of energy homeostasis. Exp Biol Med
  228. (2008). Mechanisms of leptin action and leptin resistance.
  229. (1990). Medial hypothalamic nuclei mediate serotonin's inhibitory effect on feeding behavior.
  230. (1998). Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus.
  231. (2000). Melanocortin-3 receptor mRNA expression in pro-opiomelanocortin neurones of the rat arcuate nucleus.
  232. (1990). Melanotropin receptors in the brain are differentially distributed and recognize both corticotropin and alpha-melanocyte stimulating hormone.
  233. (1996). Metergoline potentiates natural feeding and antagonizes the anorectic action of medical hypothalamic 5-hydroxytryptamine.
  234. (1998). Mice lacking melanin-concentrating hormone are hypophagic and lean.
  235. (2004). Mind versus metabolism in the control of food intake and energy balance.
  236. (2004). Minireview: A hypothalamic role in energy balance with special emphasis on leptin.
  237. (2003). Minireview: From anorexia to obesity--the yin and yang of body weight control.
  238. (1999). Model for the regulation of energy balance and adiposity by the central nervous system.
  239. (2005). Modulation of spontaneous firing in rat subthalarnic neurons by 5-HT receptor subtypes.
  240. (2002). Molecular, pharmacological and functional diversity of 5-HT receptors.
  241. (2007). Multiple conductances are modulated by 5-HT receptor subtypes in rat subthalamic nucleus neurons.
  242. (1982). Multiple connections of medial hypothalamic neurons in the rat.
  243. (1979). Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]Iysergic acid diethylamide and [3 H] spiroperidol.
  244. (2001). Multiplicity of mechanisms of serotonin receptor signal transduction.
  245. (2000). Neural connections of hypothalamic neuroendocrine nuclei in the rat.
  246. (2008). Neurocircuits integrating hormone and nutrient signaling in control of glucose metabolism.
  247. Neuronal glucosensing: what do we know after 50 years?
  248. (2006). Neuronal responses to transient hypoglycaernia in the dorsal vagal complex of the rat brainstem.
  249. (2002). Neuropeptide and hormonal signalling in mammalian central autonomic neurones.
  250. (1986). Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochernical inducer of hyperphagia and obesity. Peptides 7,1189-1192. Steinbusch HW.
  251. (1983). Neuropeptide Y distribution in human brain.
  252. (1991). Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food.
  253. (1982). Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.
  254. (2004). Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice.
  255. (1989). Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarization-activated cation current.
  256. (1990). Noradrenergic and serotonergic modulation of a hyperpolarization-activated cation current in thalamic relay neurones. i Physiol
  257. (1999). Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor.
  258. (2006). O'Kelly 1, Gerasimenko 0, Fugger L& Verkhratsky A.
  259. (2004). Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus.
  260. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein.
  261. (2000). Orexin-induced food intake involves neuropepticle Y pathway.
  262. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior.
  263. (2008). Organisation. Obesity and Overweight, accessed I
  264. (1987). Origin of serotonin innervation of the arcuate and ventromedial hypothalamic region.
  265. (1970). Origin of the nerve endings in the surface zone of the median eminence of the rat hypothalamus.
  266. (1996). Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction.
  267. (1995). PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine.
  268. (1985). Peptide YY (PYY), a potent orexigenic agent.
  269. (2002). Peripheral ghrelin selectively increases Fos expression in neuropeptide Y- synthesizing neurons in mouse hypothalamic arcuate nucleus.
  270. (1980). Phannacology of central serotonin neurons.
  271. (2007). Pharmacological and molecular characterization of ATP-sensitive K(+) conductances in CART and NPY/AgRP expressing neurons of the hypothalamic arcuate, nucleus.
  272. (1979). Phasic firing enhances vasopressin release from the rat neurohypophysis.
  273. (2004). Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons.
  274. (2002). Plasma ghrelin levels after diet-induced weight loss or gastricbypass surgery.
  275. (2003). Plasma membrane and vesicular glutarnate transporter mRNAs/proteins in hypothalamic neurons that regulate body weight.
  276. (2000). Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity.
  277. (1999). projecting to the lateral hypothalamic area.
  278. projecting to the spinal cord.
  279. (1974). Projection of medial basal hypothalamic neurones to the preoptic anterior hypothalamic areas and the paraventricular nucleus in the rat.
  280. (1997). Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus.
  281. (1990). Properties of a hyperpolarization-activated cation current and its role in rhythmic oscillation in thalamic relay neurones.
  282. (1992). Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas.
  283. (1996). Queer current and pacemaker: the hyperpolarization-activated cation current in neurons.
  284. (1991). Raiteri A
  285. (1989). Rapid increase of an immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA receptor activation.
  286. (1993). Reciprocal interaction of 5-hydroxytryptamine and cholecystokinin in the control of feeding patterns in rats.
  287. (1995). Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks.
  288. (1995). Recombinant ob protein reduces feeding and body weight in the ob/ob mouse.
  289. (1999). Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice. Psychopharmacology (Berl)
  290. (1984). Reduction of food intake and body weight by chronic intraventricular insulin infusion.
  291. (1995). Regulated expression of the neural cell adhesion molecule Ll by specific patterns of neural impulses.
  292. (1993). Regulation of alpha-melanocyte-stimulating hormone release from hypothalamic neurons.
  293. (1955). Regulation of energy intake and the body weight: the glucostatic theory and the lipostatic hypothesis.
  294. (1981). Regulation of food intake and body weight in insulin.
  295. (1993). Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways.
  296. (1999). Regulation of glucose production by the liver. Annu Rev Nutr
  297. (1997). Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice.
  298. (1995). Regulation of intracellular calcium and preprotachykinin neurotransmitter precursor gene expression by patterned electrical stimulation in rat sympathetic neurons.
  299. (1999). Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices.
  300. (1995). Regulation of proopiornelanocortin gene expression by neuropeptide Y in the rat arcuate nucleus.
  301. (1981). Relative efficiency of neural firing patterns for vasopressin release in vitro.
  302. (1996). Role of 5-HT in stress, anxiety, and depression.
  303. (1996). Role of 5-hydroxytyptamine receptor subtypes in satiety and animal models of eating disorders.
  304. (2000). Role of brain insulin receptor in control of body weight and reproduction.
  305. (2007). Role of dorsomedial hypothalamic neuropeptide Y in energy homeostasis.
  306. (1997). Role of melanocortinergic neurons in feeding and the agouti obesity syndrome.
  307. (1998). Role of the Y5 neuropeptide Y receptor in feeding and obesity.
  308. (1975). Rostral projections from the hypothalamic arcuate nucleus.
  309. (1997). SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.
  310. (1996). Serotonergic control of the organization of feeding and satiety.
  311. (2004). Serotonergic regulation of the orexin/hypocretin neurons through the 5-HTIA receptor.
  312. (2007). Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways.
  313. (2007). Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation.
  314. (1991). Serotonin and animal behaviour. In Serotonin receptor subtypes: basic and clinical aspects,
  315. (1990). Serotonin and appetite.
  316. (2007). Serotonin and energy balance: molecular mechanisms and implications for type 2 diabetes.
  317. (2001). Serotonin excites tuberomammillary neurons by activation of Na(+)/Ca(2+)-exchange.
  318. (1990). Serotonin in Alzheimer-type dementia and other dementing illnesses.
  319. (2007). Serotonin increases the excitability of the hypothalamic paraventricular nucleus magnocellular neurons.
  320. (1988). Serotonin innervation of neuropeptide Ycontaining neurons in the rat arcuate nucleus.
  321. (1991). Serotonin receptor subtypes: functional, physiological, and clinical correlates.
  322. (1996). Serotonin receptors involved in regulation of pituitaryadrenocortical function in rats.
  323. (2006). Serotonin reciprocally regulates melanocortin neurons to modulate food intake.
  324. (2000). Serotonin suppresses subthreshold and suprathreshold oscillatory activity of rat inferior olivary neurones in vitro.
  325. (1990). Serotonin-specific drugs for anxiety and depressive disorders.
  326. (1949). Serum vasoconstrictor (serotonin) the presence of creatinine in the complex; a proposed structure of the vasoconstrictor principle.
  327. (2007). Sibutramine-associated adverse effects: a practical guide for its safe use. Obes Rev.
  328. (1993). Specific regulation of immediate early genes by patterned neuronal activity.
  329. (2002). Structure and receptor binding of PYY analogs.
  330. (1997). Subtypes YJ and Y2 of the neuropeptide Y receptor are respectively expressed in proopiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus.
  331. (2008). Synergistic impairment of glucose homeostasis in ob/ob mice lacking functional serotonin 2C receptors.
  332. (2001). T-type Ca(2+) channels mediate neurotransmitter release in retinal bipolar cells.
  333. (1989). T-type calcium channels mediate the transition between tonic and phasic firing in thalamic neurons.
  334. (1997). Targeted disruption of the melanocortin-4 receptor results in obesity in mice.
  335. (2003). The 5-HTIA serotonin receptor is located on calbindin- and parvalburnin-containing neurons in the rat brain.
  336. (1996). The 5-HTIB receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence.
  337. (1995). The 5-HTIB receptor mediates the effect of d-fenfluramine on eating caused by intra-hypothalamic injection of neuropeptide Y.
  338. (1985). The A-current: how ubiquitous a feature of excitable cells is it?.
  339. (2001). The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis.
  340. (1997). The arcuate nucleus as a primary site of satiety effect of leptin in rats.
  341. (1984). The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site.
  342. (2001). The central effects of orexin-A in the hypothalamic-pituitaryadrenal axis in vivo and in vitro in male rats.
  343. (2002). The discovery and status of sibutramine as an antiobesity drug.
  344. (1983). The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat.
  345. (2003). The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis.
  346. (1999). The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
  347. (2003). The gut hormone pepticle YY regulates appetite.
  348. (1998). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.
  349. (2001). The hypothalamus and the control of energy homeostasis: different circuits, different purposes.
  350. (2000). The hypothalamus and the regulation of energy homeostasis: lifting the lid on a black box.
  351. (1992). The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochernical characterization.
  352. (1983). The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat.
  353. (1985). The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), A model of presynaptic 5-HT1 function.
  354. (2008). The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.
  355. (1979). The presence of two alpha-MSH positive cell groups in rat hypothalamus.
  356. (1998). The rat brain in slereotaxic coordinates.
  357. (1990). The regulation and function of c-fos and other immediate early genes in the nervous system.
  358. (2004). The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides.
  359. (1953). The role of depot fat in the hypothalamic control of food intake in the rat.
  360. (1995). The role of neuropeptide Y in the antiobesity action of the obese gene product.
  361. (1987). The role of putative 5-HTIA and 5-HTIB receptors in the control of feeding in rats.
  362. (1995). The role of serotonin in depression and anxiety.
  363. (1996). The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats.
  364. (1999). The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.
  365. (1986). Thermoregulatory responses to serotonin (5-HT) receptor stimulation in the rat. Evidence for opposing roles of 5-HT2 and 5-11TIA receptors.
  366. (1990). Tolbutamide excites rat glucoreceptive ventromedial hypothalamic neurones by indirect inhibition of ATP-K+ channels.
  367. (1992). Trans-synaptic regulation of gene expression.
  368. (2005). Transmembrane signaling in the brain by serotonin, a key regulator of physiology and emotion.
  369. (2006). Ttype channels-secretion coupling: evidence for a fast low-threshold exocytosis.
  370. (1986). Two brain cholecystokinin receptors: implications for behavioral actions.
  371. (1957). Two kinds of tryptamine receptor.
  372. (1997). VaIvular heart disease associated with fenfluramine-phentennine.
  373. (2006). Ventrornedial arcuate nucleus communicates peripheral metabolic information to the suprachiasmatic nucleus.
  374. (1971). Voltage clamp studies of a transient outward membrane current in gastropod neural somata.
  375. (1982). Voltage-clamp analysis of muscarinic excitation in hippocampal neurons.
  376. (1996). Voltage-dependent potassium currents of sympathetic preganglionic neurons in neonatal rat spinal cord thin slices.
  377. (2003). Weighing the role of hypothalamic feeding neurotransmitters.
  378. (1995). Weight-reducing effects of the plasma protein encoded by the obese gene.
  379. (1991). Whole-cell recordings from sympathetic preganglionic neurons in rat spinal cord slices.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.